检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘少平[1] 方春华[1] 常城[1] 张险峰[1] 胡亚华[1]
机构地区:[1]湖北理工学院附属黄石市中心医院消化科,湖北省黄石市435000
出 处:《实用医学杂志》2013年第9期1440-1442,共3页The Journal of Practical Medicine
摘 要:目的:探讨血清可溶性上皮型钙黏附蛋白(soluble epithelial cadherin,sE-cad)的含量变化与胃癌侵袭转移及复发的关系。方法:以ELISA法检测158例胃癌患者及30例正常对照者血清sE-cad与CEA的含量,并检测胃癌患者术后1个月sE-cad与CEA含量的变化。术后随访3年,肿瘤复发患者复查血清sE-cad与CEA含量。分析血清sE-cad含量变化与胃癌病理特征的关系。结果:胃癌组和复发转移组血清sE-cad、CEA含量均显著高于正常对照组(P<0.01)。术后1个月sE-cad含量降至正常范围(P﹥0.05),而CEA含量仍显著高于正常范围(P<0.01)。血清sE-cad含量与肿瘤分化程度、TNM病理分期、有无淋巴结转移、有无远处转移、浸润深度均相关(P<0.01)。结论:血清sE-cad可成为具有一定临床价值的新型胃癌肿瘤标志物,有助于术后复发的监测和预后评价。Objective To study the relationship of serum level of soluble epithelial cadherin(sE-cad)with the recurrence,invasion and metastasis of gastric cancer.Methods Serum levels of sE-cad and CEA in 30 normal controls and 158 patients with gastric cancer before and 1 month after surgery were measured by ELISA.After 3 years of follow-up,serum levels of sE-cad and CEA were also measured in the recurred gastric cancer patient.The relation between serum level of sE-cad and the pathological characteristics of gastric cancer was evaluated.Results Serum levels of sE-cad and CEA in gastric cancer group and recurred and metastasis group were significantly higher than those in control group(P〈0.01),and sE-cad level was decreased to the normal range 1 month after surgery(P〈0.05),while CEA level was still significantly higher(P〈0.01).Serum level of sE-cad in gastric cancer group was significantly correlated with the differentiation degree,the pathological staging,the lymph node metastasis,the distant metastasis,and the depth of invasion(P〈0.01).Conclusion Serum level of sE-cad could be a valuable gastric cancer marker and conduce to monitoring the recurrence and to evaluating the prognosis of gastric cancer.
关 键 词:胃肿瘤 可溶性上皮型钙黏附蛋白 侵袭转移
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249